CRWD Stock Analysis: Crowdstrike Holdings | NASDAQ
Software - Infrastructure | NASDAQ, USA | Market Cap: 171.327m USD | 12M Return: 45.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.36B
EPS Trend: 78.7%
Qual. Beats: 0
Rev. Trend: 99.6%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 7 years of data
Average return per month, with how dependable it is below — did the month move the same way every year (high) or randomly (low). Above 60 is a pattern worth trusting; under 40 is noise.
CrowdStrike Holdings (CRWD) is a US-based cybersecurity provider operating across the United States and international markets, classified within the Information Technology sector and the Application Software sub-industry. The company sells its Falcon platform and cloud modules primarily through a software-as-a-service (SaaS) subscription model, which is the dominant commercial approach in cloud-native cybersecurity and tends to produce recurring revenue. Its unified platform delivers cloud-delivered protection for endpoints, cloud workloads, identity, and data, spanning areas such as endpoint and cloud workload security, managed security, vulnerability and IT operations management, identity protection, threat intelligence, data protection, SaaS security posture management, AI-powered workflow automation, and the securing of generative AI workloads, alongside security orchestration and event/log management. CrowdStrike has formed a strategic alliance with Cognizant Technology Solutions to help enterprises secure AI across its full lifecycle. The company was incorporated in 2011, is headquartered in Austin, Texas, and completed its IPO on June 12, 2019.
- Falcon net new ARR growth accelerates subscription revenue beats
- Microsoft Defender and SentinelOne competition pressures endpoint market share
- AI workload security demand and Cognizant partnership expand addressable market
| Net Income: -24.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 2.46 > 1.0 |
| NWC/Revenue: 42.91% < 20% (prev 58.91%; Δ -16.00% < -1%) |
| CFO/TA 0.16 > 3% & CFO 1.82b > Net Income -24.5m |
| Net Debt (-3.66b) to EBITDA (334.7m): -10.92 < 3 |
| Current Ratio: 1.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (257.9m) vs 12m ago 3.80% < -2% |
| Gross Margin: 75.03% > 18% (prev 74.48%; Δ 0.55% > 0.5%) |
| Asset Turnover: 50.97% > 50% (prev 47.43%; Δ 3.54% > 0%) |
| Interest Coverage Ratio: 1.07 > 6 (EBIT TTM 29.4m / Interest Expense TTM 27.4m) |
| A: 0.19 (Total Current Assets 6.30b - Total Current Liabilities 4.12b) / Total Assets 11.3b |
| B: -0.11 (Retained Earnings -1.26b / Total Assets 11.3b) |
| C: 0.00 (EBIT TTM 29.4m / Avg Total Assets 10.00b) |
| D: 0.70 (Book Value of Equity 4.63b / Total Liabilities 6.59b) |
| Altman-Z'' = 1.67 = BB |
| DSRI: 0.94 (Receivables 933.9m/808.7m, Revenue 5.09b/4.14b) |
| GMI: 0.99 (GM 74.48% / 75.03%) |
| AQI: 1.39 (AQ_t 0.34 / AQ_t-1 0.24) |
| SGI: 1.23 (Revenue 5.09b / 4.14b) |
| TATA: -0.16 (NI -24.5m - CFO 1.82b) / TA 11.3b) |
| Beneish M = -2.71 (Cap -4..+1) = A |
As of June 30, 2026, the stock is trading at USD 742.91 with a total of 4,424,565 shares traded. Over the past week, the price has changed by +9.99%, over one month by +1.63%, over three months by +95.47% and over the past year by +45.87%.
Current recommended Stop Loss: 699.40 (which is 5.9% or 1.4 ATR below the current price).
Crowdstrike Holdings has received a consensus analysts rating of 4.27. Therefore, it is recommended to buy CRWD.
- StrongBuy: 27
- Buy: 12
- Hold: 11
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 712.4 | -4.1% |
P/E Forward = 136.9863
P/S = 33.6318
P/B = 36.9728
P/EG = 5.4773
Revenue TTM = 5.09b USD
EBIT TTM = 29.4m USD
EBITDA TTM = 334.7m USD
Long Term Debt = 745.8m USD (from longTermDebt, last quarter)
Short Term Debt = 19.9m USD (from shortTermDebt, last quarter)
Debt = 896.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 75.5m
Net Debt = -3.66b USD (calculated: Debt 896.8m - CCE 4.55b)
Enterprise Value = 168b USD (171b + Debt 896.8m - CCE 4.55b)
Interest Coverage Ratio = 1.07 (Ebit TTM 29.4m / Interest Expense TTM 27.4m)
EV/FCF = 152.7x (Enterprise Value 168b / FCF TTM 1.10b)
FCF Yield = 0.65% (FCF TTM 1.10b / Enterprise Value 168b)
FCF Margin = 21.55% (FCF TTM 1.10b / Revenue TTM 5.09b)
Net Margin = -0.48% (Net Income TTM -24.5m / Revenue TTM 5.09b)
Gross Margin = 75.03% ((Revenue TTM 5.09b - Cost of Revenue TTM 1.27b) / Revenue TTM)
Gross Margin QoQ = 75.30% (prev 76.12%)
Tobins Q-Ratio = 14.88 (Enterprise Value 168b / Total Assets 11.3b)
Interest Expense / Debt = 3.06% (Interest Expense 27.4m / Debt 896.8m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 23.2m (EBIT 29.4m * (1 - 21.00%))
Current Ratio = 1.51 (Total Current Assets 6.30b / Total Current Liabilities 4.17b)
Debt / Equity = 0.19 (Debt 896.8m / totalStockholderEquity, last quarter 4.63b)
Debt / EBITDA = -10.92 (Net Debt -3.66b / EBITDA 334.7m)
Debt / FCF = -3.33 (Net Debt -3.66b / FCF TTM 1.10b)
Total Stockholder Equity = 4.21b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.25% (Net Income -24.5m / Total Assets 11.3b)
RoE = -0.58% (Net Income TTM -24.5m / Total Stockholder Equity 4.21b)
RoCE = 0.59% (EBIT 29.4m / Capital Employed (Equity 4.21b + L.T.Debt 745.8m))
RoIC = 0.34% (NOPAT 23.2m / Invested Capital 6.92b)
WACC = 11.50% (E(171b)/V(172b) * Re(11.55%) + D(896.8m)/V(172b) * Rd(3.06%) * (1-Tc(0.21)))
Discount Rate = 11.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 51.11 | Cagr: 1.76%
[DCF] Terminal Value 68.48% ; FCFF base≈912.7m ; Y1≈1.05b ; Y5≈1.54b
[DCF] Fair Price = 72.72 (EV 14.9b - Net Debt -3.66b = Equity 18.5b / Shares 254.6m; r=11.50% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 78.66 | EPS CAGR: 17.78% | SUE: 0.58 | # QB: 0
Revenue Correlation: 99.64 | Revenue CAGR: 26.29% | SUE: 2.30 | # QB: 1
EPS current Quarter (2026-07-31): EPS=1.17 | Chg30d=+0.87% | Revisions=+38% | Analysts=42
EPS next Quarter (2026-10-31): EPS=1.24 | Chg30d=+0.98% | Revisions=+38% | Analysts=42
EPS current Year (2027-01-31): EPS=4.93 | Chg30d=+1.53% | Revisions=+88% | GrowthEPS=+32.1% | GrowthRev=+23.5%
EPS next Year (2028-01-31): EPS=6.25 | Chg30d=+1.27% | Revisions=+61% | GrowthEPS=+26.8% | GrowthRev=+21.6%
[Analyst] Revisions Ratio: +88%